Orally Active Squalene Synthase Inhibitors: Bis((acyloxy)alkyl) Prodrugs of the α-Phosphonosulfonic Acid Moiety

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVLetterNEXTOrally Active Squalene Synthase Inhibitors: Bis((acyloxy)alkyl) Prodrugs of the α-Phosphonosulfonic Acid MoietyJohn K. Dickson,, Scott A. Biller, David R. Magnin, Edward W. Petrillo,, John W. Hillyer, Dolly C. Hsieh, Shih-Jung Lan, J. Kent Rinehart, Richard E. Gregg, Thomas W. Harrity, Kern G. Jolibois, Stephen S. Kalinowski, Lori K. Kunselman, Kasim A. Mookhtiar, and Carl P. CiosekView Author Information Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, New Jersey 08543 Cite this: J. Med. Chem. 1996, 39, 3, 661–664Publication Date (Web):February 2, 1996Publication History Received5 October 1995Published online2 February 1996Published inissue 1 January 1996https://doi.org/10.1021/jm950735sCopyright © 1996 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views472Altmetric-Citations40LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (185 KB) Get e-AlertsSUBJECTS:Absorption,Inhibitors,Organic compounds,Pharmaceuticals,Rodent models Get e-Alerts